Advertisement

Native Valve Endocarditis

  • Kareem Bedeir
  • Basel RamlawiEmail author
Chapter
  • 9 Downloads

Abstract

Infective endocarditis is defined by a focus of infection within the heart and is a complex, challenging and life-threatening condition that requires multidisciplinary management regarding diagnosis, medical therapy, monitoring and surgery. It is frequently acquired in the health care setting, and more than one-half of cases now occur in patients without known heart disease. Despite optimal care, mortality remains high. The challenges posed by infective endocarditis are significant. It is heterogeneous in etiology, clinical manifestations, and course. In this chapter, we will discuss the surgical aspects of native valve endocarditis.

Keywords

Homograft Infective endocarditis Native valve endocarditis Rheumatic valvular disease Staphylococcus aureus 

References

  1. 1.
    Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88:53–60.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363:139–49.PubMedCrossRefGoogle Scholar
  4. 4.
    Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore). 1995;74:324–39.CrossRefGoogle Scholar
  5. 5.
    Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.PubMedCrossRefGoogle Scholar
  6. 6.
    Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159–e95.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521–643.PubMedGoogle Scholar
  8. 8.
    Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003;289:1933–40.PubMedCrossRefGoogle Scholar
  9. 9.
    Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA. 2003;290:3207–14.PubMedCrossRefGoogle Scholar
  10. 10.
    Aksoy O, Sexton DJ, Wang A, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007;44:364–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Croft CH, Woodward W, Elliott A, Commerford PJ, Barnard CN, Beck W. Analysis of surgical versus medical therapy in active complicated native valve infective endocarditis. Am J Cardiol. 1983;51:1650–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Richardson JV, Karp RB, Kirklin JW, Dismukes WE. Treatment of infective endocarditis: a 10-year comparative analysis. Circulation. 1978;58:589–97.PubMedCrossRefGoogle Scholar
  13. 13.
    Fernicola DJ, Roberts WC. Frequency of ring abscess and cuspal infection in active infective endocarditis involving bioprosthetic valves. Am J Cardiol. 1993;72:314–23.PubMedCrossRefGoogle Scholar
  14. 14.
    Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol. 2001;37:1069–76.PubMedCrossRefGoogle Scholar
  15. 15.
    Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med. 1991;114:635–40.PubMedCrossRefGoogle Scholar
  16. 16.
    Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med. 2000;160:2781–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110:1745–55.PubMedCrossRefGoogle Scholar
  18. 18.
    Cooper HA, Thompson EC, Laureno R, et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation. 2009;120:585–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Kane WC, Aronson SM. Cardiac disorders predisposing to embolic stroke. Stroke. 1970;1:164–72.PubMedCrossRefGoogle Scholar
  20. 20.
    Bedeir K, Reardon M, Ramlawi B. Infective endocarditis: perioperative management and surgical principles. J Thorac Cardiovasc Surg. 2014;147:1133–41.PubMedCrossRefGoogle Scholar
  21. 21.
    Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation. 2005;112:69–75.PubMedCrossRefGoogle Scholar
  22. 22.
    Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466–73.PubMedCrossRefGoogle Scholar
  23. 23.
    Tleyjeh IM, Ghomrawi HM, Steckelberg JM, et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Bedeir K, Reardon M, Ramchandani M, Singh K, Ramlawi B. Elevated stroke risk associated with femoral artery cannulation during mitral valve surgery. Semin Thorac Cardiovasc Surg. 2015;27:97–103.PubMedCrossRefGoogle Scholar
  26. 26.
    Gammie JS, Zhao Y, Peterson ED, O’Brien SM, Rankin JS, Griffith BP, Maxwell J. Chamberlain memorial paper for adult cardiac surgery. Less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2010;90:1401–8,10 e1.PubMedCrossRefGoogle Scholar
  27. 27.
    Iung B, Rousseau-Paziaud J, Cormier B, et al. Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol. 2004;43:386–92.PubMedCrossRefGoogle Scholar
  28. 28.
    de Kerchove L, Price J, Tamer S, et al. Extending the scope of mitral valve repair in active endocarditis. J Thorac Cardiovasc Surg. 2012;143:S91–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Muehrcke DD, Cosgrove DM 3rd, Lytle BW, et al. Is there an advantage to repairing infected mitral valves? Ann Thorac Surg. 1997;63:1718–24.PubMedCrossRefGoogle Scholar
  30. 30.
    Lee EM, Shapiro LM, Wells FC. Conservative operation for infective endocarditis of the mitral valve. Ann Thorac Surg. 1998;65:1087–92.PubMedCrossRefGoogle Scholar
  31. 31.
    Zegdi R, Debieche M, Latremouille C, et al. Long-term results of mitral valve repair in active endocarditis. Circulation. 2005;111:2532–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Ruttmann E, Legit C, Poelzl G, et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg. 2005;130:765–71.PubMedCrossRefGoogle Scholar
  33. 33.
    Jung SH, Je HG, Choo SJ, Song H, Chung CH, Lee JW. Surgical results of active infective native mitral valve endocarditis: repair versus replacement. Eur J Cardiothorac Surg. 2011;40:834–9.PubMedGoogle Scholar
  34. 34.
    Gammie JS, O’Brien SM, Griffith BP, Peterson ED. Surgical treatment of mitral valve endocarditis in North America. Ann Thorac Surg. 2005;80:2199–204.PubMedCrossRefGoogle Scholar
  35. 35.
    Toyoda N, Itagaki S, Egorova NN, et al. Real-world outcomes of surgery for native mitral valve endocarditis. J Thorac Cardiovasc Surg. 2017;154:1906–12 e9.PubMedCrossRefGoogle Scholar
  36. 36.
    Sternik L, Zehr KJ, Orszulak TA, Mullany CJ, Daly RC, Schaff HV. The advantage of repair of mitral valve in acute endocarditis. J Heart Valve Dis. 2002;11:91–7.PubMedGoogle Scholar
  37. 37.
    Feringa HH, Shaw LJ, Poldermans D, et al. Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg. 2007;83:564–70.PubMedCrossRefGoogle Scholar
  38. 38.
    Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 1998;98:1949–84.PubMedCrossRefGoogle Scholar
  39. 39.
    Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation. 1985;72:31–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Moon MR, Miller DC, Moore KA, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg. 2001;71:1164–71.PubMedCrossRefGoogle Scholar
  41. 41.
    Chauvaud S, Waldmann T, d'Attellis N, et al. Homograft replacement of the mitral valve in young recipients: mid-term results. Eur J Cardiothorac Surg. 2003;23:560–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Kumar AS, Choudhary SK, Mathur A, Saxena A, Roy R, Chopra P. Homograft mitral valve replacement: five years’ results. J Thorac Cardiovasc Surg. 2000;120:450–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Carpentier AF, Pellerin M, Fuzellier JF, Relland JY. Extensive calcification of the mitral valve anulus: pathology and surgical management. J Thorac Cardiovasc Surg. 1996;111:718–29. discussion 29–30PubMedCrossRefGoogle Scholar
  44. 44.
    Casselman FP, Gillinov AM, McDonald ML, Cosgrove DM 3rd. Use of the anterior mitral leaflet to reinforce the posterior mitral annulus after debridement of calcium. Ann Thorac Surg. 1999;68:261–2.PubMedCrossRefGoogle Scholar
  45. 45.
    David TE, Feindel CM, Armstrong S, Sun Z. Reconstruction of the mitral anulus. A ten-year experience. J Thorac Cardiovasc Surg. 1995;110:1323–32.PubMedCrossRefGoogle Scholar
  46. 46.
    Sabik JF, Lytle BW, Blackstone EH, Marullo AG, Pettersson GB, Cosgrove DM. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg. 2002;74:650–9. discussion 9PubMedCrossRefGoogle Scholar
  47. 47.
    Haydock D, Barratt-Boyes B, Macedo T, Kirklin JW, Blackstone E. Aortic valve replacement for active infectious endocarditis in 108 patients. A comparison of freehand allograft valves with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg. 1992;103:130–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Yankah AC, Pasic M, Klose H, Siniawski H, Weng Y, Hetzer R. Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. Eur J Cardiothorac Surg. 2005;28:69–75.PubMedCrossRefGoogle Scholar
  49. 49.
    Knosalla C, Weng Y, Yankah AC, et al. Surgical treatment of active infective aortic valve endocarditis with associated periannular abscess—11 year results. Eur Heart J. 2000;21:490–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Brigham and Women’s HospitalBostonUSA
  2. 2.Valley Health SystemWinchesterUSA

Personalised recommendations